BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28950147)

  • 1. Genomic signatures as predictive biomarkers of homologous recombination deficiency in ovarian cancer.
    Vanderstichele A; Busschaert P; Olbrecht S; Lambrechts D; Vergote I
    Eur J Cancer; 2017 Nov; 86():5-14. PubMed ID: 28950147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers.
    Watkins JA; Irshad S; Grigoriadis A; Tutt AN
    Breast Cancer Res; 2014 Jun; 16(3):211. PubMed ID: 25093514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical assays for assessment of homologous recombination DNA repair deficiency.
    Stover EH; Fuh K; Konstantinopoulos PA; Matulonis UA; Liu JF
    Gynecol Oncol; 2020 Dec; 159(3):887-898. PubMed ID: 33012552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting DNA repair: the genome as a potential biomarker.
    Nesic K; Wakefield M; Kondrashova O; Scott CL; McNeish IA
    J Pathol; 2018 Apr; 244(5):586-597. PubMed ID: 29282716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic targeting and patient selection for cancers with homologous recombination defects.
    Talens F; Jalving M; Gietema JA; Van Vugt MA
    Expert Opin Drug Discov; 2017 Jun; 12(6):565-581. PubMed ID: 28425306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Abnormalities of DNA repair and gynecological cancers].
    Auguste A; Leary A
    Bull Cancer; 2017 Nov; 104(11):971-980. PubMed ID: 29054544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair.
    Ceccaldi R; Liu JC; Amunugama R; Hajdu I; Primack B; Petalcorin MI; O'Connor KW; Konstantinopoulos PA; Elledge SJ; Boulton SJ; Yusufzai T; D'Andrea AD
    Nature; 2015 Feb; 518(7538):258-62. PubMed ID: 25642963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors.
    Joshi PM; Sutor SL; Huntoon CJ; Karnitz LM
    J Biol Chem; 2014 Mar; 289(13):9247-53. PubMed ID: 24554720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and prognostic value of mutations associated with the homologous recombination DNA repair pathway in a large pan cancer cohort.
    Principe DR; Narbutis M; Koch R; Rana A
    Sci Rep; 2020 Nov; 10(1):20223. PubMed ID: 33214570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor Response.
    Moore JA; Chen KT; Madison R; Newberg JY; Fleischmann Z; Wang S; Sharaf R; Murugesan K; Fendler BJ; Hughes J; Schrock AB; Hegde PS; Oxnard GR; Fabrizio D; Frampton GM; Antonarakis ES; Sokol ES; Jin DX
    JCO Precis Oncol; 2023 Sep; 7():e2300093. PubMed ID: 37769224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting homologous repair deficiency in breast and ovarian cancers: Biological pathways, preclinical and clinical data.
    Chartron E; Theillet C; Guiu S; Jacot W
    Crit Rev Oncol Hematol; 2019 Jan; 133():58-73. PubMed ID: 30661659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs down-regulate homologous recombination in the G1 phase of cycling cells to maintain genomic stability.
    Choi YE; Pan Y; Park E; Konstantinopoulos P; De S; D'Andrea A; Chowdhury D
    Elife; 2014 Apr; 3():e02445. PubMed ID: 24843000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Homologous recombination repair deficiency as a predictive biomarker : Basic mechanisms and detection methods].
    Pfarr N; Merkelbach-Bruse S
    Pathologe; 2021 Jul; 42(4):391-398. PubMed ID: 34152463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting homologous recombination deficiency in uterine leiomyosarcoma.
    Dall G; Vandenberg CJ; Nesic K; Ratnayake G; Zhu W; Vissers JHA; Bedő J; Penington J; Wakefield MJ; Kee D; Carmagnac A; Lim R; Shield-Artin K; Milesi B; Lobley A; Kyran EL; O'Grady E; Tram J; Zhou W; Nugawela D; Stewart KP; Caldwell R; Papadopoulos L; Ng AP; Dobrovic A; Fox SB; McNally O; Power JD; Meniawy T; Tan TH; Collins IM; Klein O; Barnett S; Olesen I; Hamilton A; Hofmann O; Grimmond S; Papenfuss AT; Scott CL; Barker HE
    J Exp Clin Cancer Res; 2023 May; 42(1):112. PubMed ID: 37143137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated, Integral, and Exploratory Biomarkers in the Development of Poly(ADP-Ribose) Polymerase Inhibitors.
    Konecny GE; Chander C; Zhang L
    Cancer J; 2021 Nov-Dec 01; 27(6):482-490. PubMed ID: 34904811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homologous Recombination Repair Deficiency: An Overview for Pathologists.
    Doig KD; Fellowes AP; Fox SB
    Mod Pathol; 2023 Mar; 36(3):100049. PubMed ID: 36788098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes.
    Timms KM; Abkevich V; Hughes E; Neff C; Reid J; Morris B; Kalva S; Potter J; Tran TV; Chen J; Iliev D; Sangale Z; Tikishvili E; Perry M; Zharkikh A; Gutin A; Lanchbury JS
    Breast Cancer Res; 2014 Dec; 16(6):475. PubMed ID: 25475740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer.
    Abkevich V; Timms KM; Hennessy BT; Potter J; Carey MS; Meyer LA; Smith-McCune K; Broaddus R; Lu KH; Chen J; Tran TV; Williams D; Iliev D; Jammulapati S; FitzGerald LM; Krivak T; DeLoia JA; Gutin A; Mills GB; Lanchbury JS
    Br J Cancer; 2012 Nov; 107(10):1776-82. PubMed ID: 23047548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Can new molecular profiles in epithelial ovarian cancer modify therapeutics?].
    Lavoué V; Rousselin A; Delplanque S; Pinsard M; Henno S; Foucher F; Levêque J; de la Motte Rouge T
    J Gynecol Obstet Hum Reprod; 2017 Feb; 46(2):107-112. PubMed ID: 28403964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting the mutational signature of homologous recombination deficiency in clinical samples.
    Gulhan DC; Lee JJ; Melloni GEM; Cortés-Ciriano I; Park PJ
    Nat Genet; 2019 May; 51(5):912-919. PubMed ID: 30988514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.